Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening — Teresa Seum (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening
Shared by
Hermann Brenner
Next-Generation Multitarget Stool DNA vs Fecal Immunochemical Test in Colorectal Cancer Screening
Letter
2024
en
Authors
+2 more
TS
Teresa Seum
TN
Tobias Niedermaier
TH
Thomas Heisser
Abstract
1 min read
This diagnostic study compares the specificity and sensitivity of comercial fecal immunochemical tests with a multitarget stool DNA test.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2024
Lowering Fecal Immunochemical Test Positivity Threshold vs Multitarget Stool RNA Testing for Colorectal Cancer Screening
Tobias Niedermaier
,
Teresa Seum
,
Michael Hoffmeister
,
Hermann Brenner
Article
2025
Cell‐free DNA blood‐based test compared to fecal immunochemical test for colorectal cancer screening
Teresa Seum
,
Michael Hoffmeister
,
Hermann Brenner
Article
2025
Diagnostic performance of a circulating tumor DNA‐based blood test compared to fecal immunochemical test in colorectal cancer screening
Hermann Brenner
,
Teresa Seum
,
Megha Bhardwaj
,
Michael Hoffmeister
Editorial Material
2024
Making the best use of quantitative fecal immunochemical test results in colorectal cancer screening
Hermann Brenner
,
Michael Hoffmeister
Article
2026
Head‐to‐head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection
Xianzhe Li
,
Zitong Zhao
,
L. P. S. Stassen
,
Anjana Pradeep Maya
,
Megha Bhardwaj
,
Teresa Seum
,
Janhavi R. Raut
,
Tafirenyika Gwenzi
,
Michael Hoffmeister
,
Petra Schrotz‐King
,
Hermann Brenner
Discussion(0)
No comments yet. Be the first to comment.